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Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation Lun, 29/07/2013 -13:13 -admin Gruppo di Ricerca: Ida Paciello Lipopolysaccharide (LPS) is a potent bacterial effector triggering the activation of the innate immune system following binding with the complex CD14, MD-2 and TLR4. The LPS of the enteropathogen Shigella flexneri is a hexa-acylated isoform possessing an optimal inflammatory activity. Symptoms of shigellosis are produced by severe inflammation due to the invasion process of Shigella in colonic and rectal mucosa. Here we addressed the question of the role played by the Shigella LPS in eliciting a dysregulated inflammatory response of the host. We unveil that (i) Shigella is able to modify the LPS composition, e.g. the lipid A and core domains, during proliferation within epithelial cells; (ii) the LPS of intracellular bacteria (iLPS) and that of bacteria grown in laboratory medium (eLPS) differ in the number of acyl chains in lipid A, iLPS being the hypo-acylated; (iii) the immunopotential of iLPS is dramatically lower than that of eLPS; (iv) both LPS forms mainly signal through the TLR4/MyD88 pathway; (v) iLPS down-regulates the inflammasomemediated release of IL-1? in Shigella-infected macrophages; and (vi) iLPS exhibits a reduced capacity to prime PMNs for an oxidative burst. We hypothesized that the two forms of LPS might govern different steps of the invasive process of Shigella. In the first phases the bacteria, decorated with hypo-acylated LPS, are able to lower the immune system surveillance, while in the late phases Shigella harboring immunopotent LPS are fully recognized by the immune system which can then successfully resolve the infection.
